Last updated on August 2019

A Study to Explore the Antiviral Activity Clinical Outcomes Safety Tolerability and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus


Brief description of study

The purpose of this study is to explore the antiviral effect of JNJ-53718678 at 2 dose levels (80 milligrams [mg] and 500 mg) once daily for 7 days in adults with Respiratory Syncytial Virus (RSV) infection, as measured by RSV viral load in nasal secretions by quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay.

Detailed Study Description

This study will be performed to explore the antiviral activity, clinical outcomes, safety, tolerability, and pharmacokinetics of JNJ-53718678 in adult participants infected with RSV. The study will include both participants who are otherwise healthy (ie, without underlying condition) or who have comorbid conditions (eg, asthma, chronic obstructive pulmonary disease (COPD), cardiovascular disease, other chronic diseases), with the exception of immunocompromised participants, presenting for medical care but not requiring hospitalization. The study will include a screening period (Day -1 to Day 1), a treatment Period (Day 1 to Day 8), and a follow-up period (Day 9 to Day 28). Safety evaluations will include adverse events, laboratory tests, electrocardiogram, vital signs, physical examination, and specific toxicities.

Clinical Study Identifier: NCT03379675

Find a site near you

Start Over

Core Healthcare Group

Cerritos, CA United States
  Connect »

eStudySite

Chula Vista, CA United States
  Connect »

SC Clinical Research Inc

Garden Grove, CA United States
  Connect »

Family Medicine

Nampa, ID United States
  Connect »

William Beaumont Hospital

Royal Oak, MI United States
  Connect »

Onsite Clinical Solutions

Charlotte, NC United States
  Connect »

Unity Clinical Research

Lindsay, OK United States
  Connect »

Spectrum Medical Research

Gaffney, SC United States
  Connect »

Hospital Privado - Centro Medico de Cordoba

Barrio Parque Velez Sarfield, Argentina
  Connect »

Hospital Italiano de La Plata

Ciudad De La Plata, Argentina
  Connect »

Hospital Rawson

Cordoba, Argentina
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Sanatorio Juan XXIII

General Roca, Argentina
  Connect »

Clinica Mayo de UMCB

San Miguel de Tucuman, Argentina
  Connect »

Mater Hospital Brisbane

South Brisbane, Australia
  Connect »

CHU Saint-Pierre

Bruxelles, Belgium
  Connect »

Testumed

Tessenderlo, Belgium
  Connect »

Gachon University Gil Hospital

Incheon, Korea, Republic of
  Connect »

Inha University Hospital

Incheon, Korea, Republic of
  Connect »

Krasnogorsk city hospital #1

Krasnogorsk, Russian Federation
  Connect »

Clinic Bessalar

Moscow, Russian Federation
  Connect »

LLC 'Medical centr 'Reavita Med Spb'

Saint-Petersburg, Russian Federation
  Connect »

Eco-safety Ltd

Saint-Petersburg, Russian Federation
  Connect »

Research Institute of Influenza

St. Petersburg, Russian Federation
  Connect »

Soweto Clinical Trial Centre

Johannesburg, South Africa
  Connect »

Newtown Clinical Research

Johannesburg, South Africa
  Connect »

Emmed Research

Pretoria, South Africa
  Connect »

Hosp. Del Mar

Barcelona, Spain
  Connect »

Hosp. Clinico Univ. de Santiago

Santiago de Compostela, Spain
  Connect »

Ashgate Medical Practice

Chesterfield, United Kingdom
  Connect »

My Health Group

York, United Kingdom
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Saino Clinic

Tokorozawa-shi, Japan
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Hospital Cordoba

Córdoba, Argentina
  Connect »

Hosp. Clinico Univ. de Santiago

Santiago De Compostela, Spain
  Connect »